Patents by Inventor Soren Peter Olsen

Soren Peter Olsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Chemical compounds having ion channel blocking activity for the treatment of immune dysfunction
    Patent number: 6797694
    Abstract: The present invention relates to chemical compounds having inhibitory activity on an intermediate conductance Ca2+ activated potassium channel (IKCa), and the use of such compounds for the treatment or alleviation of diseases or conditions relating to immune dysfunction.
    Type: Grant
    Filed: November 9, 2001
    Date of Patent: September 28, 2004
    Assignee: Poseidon Pharmaceuticals A/S
    Inventors: Bo Skaaning Jensen, Soren Peter Olsen, Palle Christophersen
  • Chemical compounds having ion channel blocking activity for the treatment of immune dysfunction
    Patent number: 6545028
    Abstract: This invention relates to treatment or alleviation of a disease, condition or disorder selected from inflammatory bowel disease, Chron's disease, colitis ulcerosa, Coeliac disease, dermatitis herpetiformis, dermatomyositis, enteritis allergia, erytherma nodosum leprosum, ileitis regionalis, psoriasis, purpura, scleritis or scleroderma by administering to a living body certain imidazole, triazole, or 1,4-dihydropyridine derivatives.
    Type: Grant
    Filed: April 14, 2000
    Date of Patent: April 8, 2003
    Assignee: NeuroSearch A/S
    Inventors: Bo S. Jensen, Søren-Peter Olsen, Tino D. Jørgensen, Dorte Strøbæk, Palle Christophersen, Niels Ødum
  • Chemical compounds having ion channel blocking activity for the treatment of immune dysfunction
    Publication number: 20020119989
    Abstract: The present invention relates to chemical compounds having inhibitory activity on an intermediate conductance Ca 2+ activated potassium channel (IK Ca), and the use of such compounds for the treatment or alleviation of diseases or conditions relating to immune dysfunction. Moreover, the invention relates to a method of screening a chemical compound for inhibitory activity on an intermediate conductance Ca 2+ activated potassium channel (IK Ca).
    Type: Application
    Filed: April 14, 2000
    Publication date: August 29, 2002
    Inventors: Bo S. Jensen, Soren-Peter Olsen, Tino D. Jorgensen, Dorte Strobaek, Palle Christophersen
  • Chemical compounds having ion channel blocking activity for the treatment of immune dysfunction
    Publication number: 20020065247
    Abstract: The present invention relates to chemical compounds having inhibitory activity on an intermediate conductance Ca2+ activated potassium channel (IKCa), and the use of such compounds for the treatment or alleviation of diseases or conditions relating to immune dysfunction.
    Type: Application
    Filed: November 9, 2001
    Publication date: May 30, 2002
    Inventors: Bo Skaaning Jensen, Soren Peter Olsen, Palle Christophersen